Abstract
Both bleeding and allogeneic blood transfusion independently increase morbidity, mortality, length of stay in ICU and in hospital, as well as hospital costs. Furthermore, ischemic and thromboembolic events are associated with increased in-hospital and posthospital costs.
Lysine analogues (tranexamic acid and ε-aminocaproic acid) reduce perioperative blood loss and transfusion requirements and can be highly cost-effective in numerous major surgery and trauma settings. In contrast, the use of rFVIIa should be restricted to its licensed indications since outside of these its effectiveness in reducing transfusion requirements and mortality remains unproven, while the risk of arterial thromboembolic events and costs are high.
Cell salvage has been shown to be cost-effective in minimizing perioperative transfusion of allogeneic blood products. The current literature does not clarify whether a formula-driven transfusion protocol reduces or increases hospital costs. On the other hand, implementation of transfusion and coagulation management algorithms based on point-of-care testing (thromboelastometry/thromboelastography or whole blood impedance aggregometry) can reduce both adverse events and costs associated with transfusion in trauma, cardiac surgery, and liver transplantation. In these settings, first-line, calculated, goal-directed therapy with coagulation factor concentrates (fibrinogen concentrate and/or prothrombin complex concentrate), guided by thromboelastometry, seems to be effective in reducing transfusion-associated costs in selected patients, without increasing the incidence of thromboembolic events.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abraham I, Sun D (2012) The cost of blood transfusion in Western Europe as estimated from six studies. Transfusion 52(9):1983–1988
Agrawal S, Davidson N, Walker M, Gibson S, Morgan CL, Cowell W (2006) Assessing the total costs of blood delivery to hospital oncology and haematology patients. Curr Med Res Opin 22(10):1903–1909
Association of Anaesthetists of Great Britain and Ireland, Thomas D, Wee M, Clyburn P, Walker I, Brohi K, Collins P, Doughty H, Isaac J, Mahoney PM, Shewry L (2010) Blood transfusion and the anaesthetist: management of massive haemorrhage. Anaesthesia 65(11):1153–1161
Avidan MS, Alcock EL, Da Fonseca J, Ponte J, Desai JB, Despotis GJ, Hunt BJ (2004) Comparison of structured use of routine laboratory tests or near-patient assessment with clinical judgement in the management of bleeding after cardiac surgery. Br J Anaesth 92(2):178–186
Berenson K, Casciano R, Makenbaeva D, Mozaffari E, Lamerato L, Corbelli J (2010) Economic consequences of severe bleeding in patients with acute coronary syndrome in the USA. Adv Ther 27(8):564–579
Boffard KD, Riou B, Warren B, Choong PI, Rizoli S, Rossaint R, Axelsen M, Kluger Y, NovoSeven Trauma Study Group (2005) Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma 59(1):8–15
Borgman MA, Spinella PC, Holcomb JB, Blackbourne LH, Wade CE, Lefering R, Bouillon B, Maegele M (2011) The effect of FFP:RBC ratio on morbidity and mortality in trauma patients based on transfusion prediction score. Vox Sang 101:44–54
Brown JR, Birkmeyer NJ, O'Connor GT (2007) Meta-analysis comparing the effectiveness and adverse outcomes of antifibrinolytic agents in cardiac surgery. Circulation 115(22):2801–2813
Bufe A, Frey S, Briswalter S (2009) Costs caused by bleeds within the therapy of acute coronary syndromes in Germany. Herz 34(6):479–484. [Article in German]
Callum JL, Rizoli S (2012a) Assessment and management of massive bleeding: coagulation assessment, pharmacologic strategies, and transfusion management. Hematol Am Soc Hematol Educ Progr 2012:522–528
Callum JL, Rizoli S (2012b) Plasma transfusion for patients with severe hemorrhage: what is the evidence? Transfusion 52(Suppl 1):30S–37S
Carless PA, Henry DA, Moxey AJ, O'Connell D, Brown T, Fergusson DA (2010) Cell salvage for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev (4):CD001888
Chavez-Tapia NC, Alfaro-Lara R, Tellez-Avila F, Barrientos-Gutiérrez T, González-Chon O, Mendez-Sanchez N, Uribe M (2011) Prophylactic activated recombinant factor VII in liver resection and liver transplantation: systematic review and meta-analysis. PLoS One 6(7):e22581
Christensen MC, Krapf S, Kempel A, von Heymann C (2009) Costs of excessive postoperative hemorrhage in cardiac surgery. J Thorac Cardiovasc Surg 138(3):687–693
Cotton BA, Gunter OL, Isbell J, Au BK, Robertson AM, Morris JA Jr, St Jacques P, Young PP (2008) Damage control hematology: the impact of a trauma exsanguination protocol on survival and blood product utilization. J Trauma 64(5):1177–1182
Cotton BA, Au BK, Nunez TC, Gunter OL, Robertson AM, Young PP (2009) Predefined massive transfusion protocols are associated with a reduction in organ failure and postinjury complications. J Trauma 66(1):41–48
CRASH-2 Collaborators, Roberts I, Shakur H, Afolabi A, Brohi K, Coats T, Dewan Y, Gando S, Guyatt G, Hunt BJ, Morales C, Perel P, Prieto-Merino D, Woolley T (2011) The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet 377(9771):1096–1101, 1101.e1–1102
CRASH-2 Trial Collaborators, Shakur H, Roberts I, Bautista R, Caballero J, Coats T, Dewan Y, El-Sayed H, Gogichaishvili T, Gupta S, Herrera J, Hunt B, Iribhogbe P, Izurieta M, Khamis H, Komolafe E, Marrero MA, Mejía-Mantilla J, Miranda J, Morales C, Olaomi O, Olldashi F, Perel P, Peto R, Ramana PV, Ravi RR, Yutthakasemsunt S (2010) Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 376(9734):23–32
Cushing M, Shaz BH (2011) Blood transfusion in trauma patients: unresolved questions. Minerva Anestesiol 77(3):349–359
Dasta JF, McLaughlin TP, Mody SH, Piech CT (2005) Daily cost of an intensive care unit day: the contribution of mechanical ventilation. Crit Care Med 33(6):1266–1271
Davenport R, Manson J, De'Ath H, Platton S, Coates A, Allard S, Hart D, Pearse R, Pasi KJ, MacCallum P, Stanworth S, Brohi K (2011) Functional definition and characterization of acute traumatic coagulopathy. Crit Care Med 39(12):2652–2658
Davies L, Brown TJ, Haynes S, Payne K, Elliott RA, McCollum C (2006) Cost-effectiveness of cell salvage and alternative methods of minimising perioperative allogeneic blood transfusion: a systematic review and economic model. Health Technol Assess 10(44):iii–iv, ix–x, 1–210
Dente CJ, Shaz BH, Nicholas JM, Harris RS, Wyrzykowski AD, Patel S, Shah A, Vercruysse GA, Feliciano DV, Rozycki GS, Salomone JP, Ingram WL (2009) Improvements in early mortality and coagulopathy are sustained better in patients with blunt trauma after institution of a massive transfusion protocol in a civilian level I trauma center. J Trauma 66(6):1616–1624
Dobesh PP (2009) Economic burden of venous thromboembolism in hospitalized patients. Pharmacotherapy 29(8):943–953
Ducloy-Bouthors AS, Jude B, Duhamel A, Broisin F, Huissoud C, Keita-Meyer H, Mandelbrot L, Tillouche N, Fontaine S, Le Goueff F, Depret-Mosser S, Vallet B, EXADELI Study Group, Susen S (2011) High-dose tranexamic acid reduces blood loss in postpartum haemorrhage. Crit Care 15(2):R117
Dutton R, Hauser C, Boffard K, Dimsitts J, Bernard G, Holcomb J, Leppäniemi A, Tortella B, Bouillon B, CONTROL Steering Committee (2009) Scientific and logistical challenges in designing the CONTROL trial: recombinant factor VIIa in severe trauma patients with refractory bleeding. Clin Trials 6(5):467–479
Dzik WH, Blajchman MA, Fergusson D, Hameed M, Henry B, Kirkpatrick AW, Korogyi T, Logsetty S, Skeate RC, Stanworth S, MacAdams C, Muirhead B (2011) Clinical review: Canadian National Advisory Committee on Blood and Blood Products – massive transfusion consensus conference 2011: report of the panel. Crit Care 15(6):242
Esler C, Ghag S, Kirstenfeld C, Fung YL, Pearse B (2013) Health Services Support Agency (HSSA): Implementation of ROTEM® (Rotational thromboelastometry) in cardiac theatre reduces use of blood products. Poster, HAA 20–23. Queensland, Australia
Fergusson DA, Hébert PC, Mazer CD, Fremes S, MacAdams C, Murkin JM, Teoh K, Duke PC, Arellano R, Blajchman MA, Bussières JS, Côté D, Karski J, Martineau R, Robblee JA, Rodger M, Wells G, Clinch J, Pretorius R, BART Investigators (2008) A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med 358(22):2319–2331
Ferrer P, Roberts I, Sydenham E, Blackhall K, Shakur H (2009) Anti-fibrinolytic agents in postpartum haemorrhage: a systematic review. BMC Pregnancy Childbirth 9:29
Gill R, Herbertson M, Vuylsteke A, Olsen PS, von Heymann C, Mythen M, Sellke F, Booth F, Schmidt TA (2009) Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the setting of bleeding after cardiac surgery. Circulation 120(1):21–27
Girdauskas E, Kempfert J, Kuntze T, Borger MA, Enders J, Fassl J, Falk V, Mohr FW (2010) Thromboelastometrically guided transfusion protocol during aortic surgery with circulatory arrest: a prospective, randomized trial. J Thorac Cardiovasc Surg 140(5):1117–1124.e2
Glance LG, Dick AW, Mukamel DB, Fleming FJ, Zollo RA, Wissler R, Salloum R, Meredith UW, Osler TM (2011) Association between intraoperative blood transfusion and mortality and morbidity in patients undergoing noncardiac surgery. Anesthesiology 114(2):283–292
Glenngård AH, Persson U, Söderman C (2005) Costs associated with blood transfusions in Sweden – the societal cost of autologous, allogeneic and perioperative RBC transfusion. Transfus Med 15(4):295–306
Goerlinger K, Dirkmann D, Müller-Beißenhirtz H, Paul A, Hartmann M, Saner F (2010) Coagulation management during liver transplantation. Inflamm Res 59(Suppl 1):S147–S148
Gombotz H (2012) Patient blood management: a patient-orientated approach to blood replacement with the goal of reducing anemia, blood loss and the need for blood transfusion in elective surgery. Transfus Med Hemother 39(2):67–72
Goobie SM, Meier PM, Pereira LM, McGowan FX, Prescilla RP, Scharp LA, Rogers GF, Proctor MR, Meara JG, Soriano SG, Zurakowski D, Sethna NF (2011) Efficacy of tranexamic acid in pediatric craniosynostosis surgery: a double-blind, placebo-controlled trial. Anesthesiology 114(4):862–871
Goodnough LT, Shander A (2012) Patient blood management. Anesthesiology 116(6):1367–1376
Görlinger K (2012) Panta rhei: blood, professional career and anesthesiological self-conception. Anaesthesist 61(6):481–482
Görlinger K, Schlenke P (2012) Patient blood management: clinical hemotherapy and hemostasis management in perioperative settings. Transfus Med Hemother 39(2):57–58
Görlinger K, Jambor C, Hanke AA et al (2007) Perioperative coagulation management and control of platelet transfusion by point-of-care platelet function analysis. Transfus Med Hemother 34:396–411
Görlinger K, Moog R, Saner F, Müller-Beißenhirtz H (2008) Einfluss eines Point-of-Care- und Faktorenkonzentrate-basierten Gerinnungsmanagements auf den Transfusionsbedarf und die Kostenentwicklung am Universitätsklinikum Essen. Anästh Intensivmed 49(Suppl 7):S226
Görlinger K, Dirkmann D, Müller-Beißenhirtz H, Paul A, Hartmann M, Saner F (2010) Thromboelastometry-based perioperative coagulation management in visceral surgery and liver transplantation: experience of 10 years and 1105 LTX. Liver Transplant 16(Suppl 1):S86
Görlinger K, Dirkmann D, Hanke AA, Kamler M, Kottenberg E, Thielmann M, Jakob H, Peters J (2011a) First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study. Anesthesiology 115(6):1179–1191
Görlinger K, Dirkmann D, Weber CF et al (2011b) Algorithms for transfusion and coagulation management in massive haemorrhage. Anästh Intensivmed 52:145–159
Görlinger K, Fries D, Dirkmann D, Weber CF, Hanke AA, Schöchl H (2012) Reduction of fresh frozen plasma requirements by perioperative point-of-care coagulation management with early calculated goal-directed therapy. Transfus Med Hemother 39(2):104–113
Görlinger K, Dirkmann D, Hanke AA (2013) Potential value of transfusion protocols in cardiac surgery. Curr Opin Anaesthesiol 26(2):230–243
Greiff G, Stenseth R, Wahba A, Videm V, Lydersen S, Irgens W, Bjella L, Pleym H (2012) Tranexamic acid reduces blood transfusions in elderly patients undergoing combined aortic valve and coronary artery bypass graft surgery: a randomized controlled trial. J Cardiothorac Vasc Anesth 26(2):232–238
Griffee MJ, Deloughery TG, Thorborg PA (2010) Coagulation management in massive bleeding. Curr Opin Anaesthesiol 23(2):263–268
Grottke O, Braunschweig T, Spronk HM, Esch S, Rieg AD, van Oerle R, ten Cate H, Fitzner C, Tolba R, Rossaint R (2011) Increasing concentrations of prothrombin complex concentrate induce disseminated intravascular coagulation in a pig model of coagulopathy with blunt liver injury. Blood 118(7):1943–1951
Guerriero C, Cairns J, Jayaraman S, Roberts I, Perel P, Shakur H (2010) Giving tranexamic acid to reduce surgical bleeding in sub-Saharan Africa: an economic evaluation. Cost Eff Resour Alloc 8(1):1
Guerriero C, Cairns J, Perel P, Shakur H, Roberts I (2011) CRASH 2 trial collaborators. Cost-effectiveness analysis of administering tranexamic acid to bleeding trauma patients using evidence from the CRASH-2 trial. PLoS One 6(5):e18987
Gurusamy KS, Li J, Sharma D, Davidson BR (2009) Pharmacological interventions to decrease blood loss and blood transfusion requirements for liver resection. Cochrane Database Syst Rev (4):CD008085
Haas T, Spielmann N, Mauch J, Madjdpour C, Speer O, Schmugge M, Weiss M (2012a) Comparison of thromboelastometry (ROTEM®) with standard plasmatic coagulation testing in paediatric surgery. Br J Anaesth 108(1):36–41
Haas T, Spielmann N, Mauch J, Speer O, Schmugge M, Weiss M (2012b) Reproducibility of thrombelastometry (ROTEM®): point-of-care versus hospital laboratory performance. Scand J Clin Lab Invest 72(4):313–317
Hanke AA, Herold U, Dirkmann D, Tsagakis K, Jakob H, Görlinger K (2012) Thromboelastometry based early goal-directed coagulation management reduces blood transfusion requirements, adverse events, and costs in acute type A aortic dissection: a pilot study. Transfus Med Hemother 39(2):121–128
Hanke AA, Joch C, Görlinger K (2013) Long-term safety and efficacy of a pasteurized nanofiltrated prothrombin complex concentrate (Beriplex P/N): a pharmacovigilance study. Br J Anaesth 110:1–9. doi:10.1093/bja/aes501. [Published online 2013 Jan 18]
Hauser CJ, Boffard K, Dutton R, Bernard GR, Croce MA, Holcomb JB, Leppaniemi A, Parr M, Vincent JL, Tortella BJ, Dimsits J, Bouillon B, CONTROL Study Group (2010) Results of the CONTROL trial: efficacy and safety of recombinant activated Factor VII in the management of refractory traumatic hemorrhage. J Trauma 69(3):489–500
Henry DA, Carless PA, Moxey AJ, O’Connell D, Stokes BJ, Fergusson DA, Ker K (2011) Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev (3):CD001886
Ho KM, Litton E (2012) Cost-effectiveness of using recombinant activated factor VII as an off-label rescue treatment for critical bleeding requiring massive transfusion. Transfusion 52(8):1696–1702
Ho AM, Dion PW, Yeung JH, Holcomb JB, Critchley LA, Ng CS, Karmakar MK, Cheung CW, Rainer TH (2012) Prevalence of survivor bias in observational studies on fresh frozen plasma: erythrocyte ratios in trauma requiring massive transfusion. Anesthesiology 116(3):716–728
Holcomb JB, Wade CE, Michalek JE, Chisholm GB, Zarzabal LA, Schreiber MA, Gonzalez EA, Pomper GJ, Perkins JG, Spinella PC, Williams KL, Park MS (2008) Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients. Ann Surg 248(3):447–458
Howes JL, Smith RS, Helmer SD, Helmer SD, Taylor SM (2009) Complications of recombinant activated human coagulation factor VII. Am J Surg 198(6):895–899
Ickx BE, van der Linden PJ, Melot C, Wijns W, de Pauw L, Vandestadt J, Hut F, Pradier O (2006) Comparison of the effects of aprotinin and tranexamic acid on blood loss and red blood cell transfusion requirements during the late stages of liver transplantation. Transfusion 46(4):595–605
Inaba K, Branco BC, Rhee P, Blackbourne LH, Holcomb JB, Teixeira PG, Shulman I, Nelson J, Demetriades D (2010) Impact of plasma transfusion in trauma patients who do not require massive transfusion. J Am Coll Surg 210(6):957–965
Innerhofer P, Westermann I, Tauber H, Breitkopf R, Fries D, Kastenberger T, El Attal R, Strasak A, Mittermayr M (2013) The exclusive use of coagulation factor concentrates enables reversal of coagulopathy and decreases transfusion rates in patients with major blunt trauma. Injury 44(2):209–216
James AH, McLintock C, Lockhart E (2012) Postpartum hemorrhage: when uterotonics and sutures fail. Am J Hematol 87(Suppl 1):S16–S22
Johansson PI (2007) The blood bank: from provider to partner in treatment of massively bleeding patients. Transfusion 47(2 Suppl):176S–181S
Johansson PI (2010) Goal-directed hemostatic resuscitation for massively bleeding patients: the Copenhagen concept. Transfus Apher Sci 43(3):401–405
Johansson PI (2012) Coagulation monitoring of the bleeding traumatized patient. Curr Opin Anaesthesiol 25(2):235–241
Johansson PI, Stensballe J (2009) Effect of Haemostatic Control Resuscitation on mortality in massively bleeding patients: a before and after study. Vox Sang 96(2):111–118
Johansson PI, Stensballe J (2010) Hemostatic resuscitation for massive bleeding: the paradigm of plasma and platelets – a review of the current literature. Transfusion 50(3):701–710
Johansson PI, Stensballe J, Ostrowski SR (2012) Current management of massive hemorrhage in trauma. Scand J Trauma Resusc Emerg Med 20:47
Johnson JL, Moore EE, Kashuk JL, Banerjee A, Cothren CC, Biffl WL, Sauaia A (2010) Effect of blood products transfusion on the development of postinjury multiple organ failure. Arch Surg 145(10):973–977
Kaushal R, Bates DW, Franz C, Soukup JR, Rothschild JM (2007) Costs of adverse events in intensive care units. Crit Care Med 35(11):2479–2483
Khan H, Belsher J, Yilmaz M, Afessa B, Winters JL, Moore SB, Hubmayr RD, Gajic O (2007) Fresh-frozen plasma and platelet transfusions are associated with development of acute lung injury in critically ill medical patients. Chest 131(5):1308–1314
Kirchner C, Goerlinger K, Dirkmann D, Schumann R, Treckmann J, Paul A, Saner FH (2012) Safety and efficacy of prothrombin complex and fibrinogen concentrates in liver transplantation. Liver Transplant 18(Suppl 1):S189
Kozek-Langenecker SA (2010) Perioperative coagulation monitoring. Best Pract Res Clin Anaesthesiol 24(1):27–40
Kozek-Langenecker S, Sørensen B, Hess JR, Spahn DR (2011) Clinical effectiveness of fresh frozen plasma compared with fibrinogen concentrate: a systematic review. Crit Care 15(5):R239
Kozek-Langenecker SA, Afshari A, Albaladejo P et al (2013) Guidelines on the management of severe perioperative bleeding. Eur J Anaesthesiol 30(6):270–382
Leahy MF, Mukhtar SA (2012) From blood transfusion to patient blood management: a new paradigm for patient care and cost assessment of blood transfusion practice. Intern Med J 42(3):332–338
Levi M, Levy JH, Andersen HF, Truloff D (2010) Safety of recombinant activated factor VII in randomized clinical trials. N Engl J Med 363(19):1791–1800
Levy JH, Dutton RP, Hemphill JC 3rd, Shander A, Cooper D, Paidas MJ, Kessler CM, Holcomb JB, ; Hemostasis Summit Participants JH (2010) Multidisciplinary approach to the challenge of hemostasis. Anesth Analg 110(2):354–364
Lier H, Vorweg M, Hanke A, Görlinger K (2013) Thromboelastometry guided therapy of severe bleeding. Essener Runde algorithm. Hamostaseologie 33(1):51–61
Lin Y, Moltzan CJ, Anderson DR, National Advisory Committee on Blood and Blood Products (2012) The evidence for the use of recombinant factor VIIa in massive bleeding: revision of the transfusion policy framework. Transfus Med 22(6):383–394
Liumbruno G, Bennardello F, Lattanzio A, Piccoli P, Rossetti G, Italian Society of Transfusion Medicine and Immunohaematology (SIMTI) Work Group (2009) Recommendations for the transfusion of plasma and platelets. Blood Transfus 7(2):132–150
Lodge JP, Jonas S, Jones RM, Olausson M, Mir-Pallardo J, Soefelt S, Garcia-Valdecasas JC, McAlister V, Mirza DF, rFVIIa OLT Study Group (2005) Efficacy and safety of repeated perioperative doses of recombinant factor VIIa in liver transplantation. Liver Transpl 11(8):973–979
Maegele M, Lefering R, Paffrath T, Tjardes T, Simanski C, Bouillon B, Working Group on Polytrauma of the German Society of Trauma Surgery (DGU) (2008) Red-blood-cell to plasma ratios transfused during massive transfusion are associated with mortality in severe multiple injury: a retrospective analysis from the Trauma Registry of the Deutsche Gesellschaft für Unfallchirurgie. Vox Sang 95(2):112–119
Maegele M, Brockamp T, Nienaber U, Probst C, Schoechl H, Görlinger K, Spinella P (2012) Predictive models and algorithms for the need of transfusion including massive transfusion in severely injured patients. Transfus Med Hemother 39(2):85–97
Majeed A, Eelde A, Agren A, Schulman S, Holmström M (2012) Thromboembolic safety and efficacy of prothrombin complex concentrates in the emergency reversal of warfarin coagulopathy. Thromb Res 129(2):146–151
Manco-Johnson MJ, Dimichele D, Castaman G, Fremann S, Knaub S, Kalina U, Peyvandi F, Piseddu G, Mannucci P, Fibrinogen Concentrate Study Group (2009) Pharmacokinetics and safety of fibrinogen concentrate. J Thromb Haemost 7(12):2064–2069
Mangano DT, Tudor IC, Dietzel C, Multicenter Study of Perioperative Ischemia Research Group; Ischemia Research and Education Foundation (2006) The risk associated with aprotinin in cardiac surgery. N Engl J Med 354(4):353–365
Marik PE, Corwin HL (2008) Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature. Crit Care Med 36(9):2667–2674
Markova V, Sørensen JL, Holm C, Nørgaard A, Langhoff-Roos J (2012) Evaluation of multi-professional obstetric skills training for postpartum hemorrhage. Acta Obstet Gynecol Scand 91(3):346–352
Martin K, Breuer T, Gertler R, Hapfelmeier A, Schreiber C, Lange R, Hess J, Wiesner G (2011) Tranexamic acid versus ε-aminocaproic acid: efficacy and safety in paediatric cardiac surgery. Eur J Cardiothorac Surg 39(6):892–897
Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN, Skolnick BE, Steiner T, Recombinant Activated Factor VII Intracerebral Hemorrhage Trial Investigators (2005) Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 352(8):777–785
Mehta RH, Sheng S, O'Brien SM, Grover FL, Gammie JS, Ferguson TB, Peterson ED, Society of Thoracic Surgeons National Cardiac Surgery Database Investigators (2009) Reoperation for bleeding in patients undergoing coronary artery bypass surgery: incidence, risk factors, time trends, and outcomes. Circ Cardiovasc Qual Outcomes 2(6):583–590
Milligan C, Higginson I, Smith JE (2011) Emergency department staff knowledge of massive transfusion for trauma: the need for an evidence based protocol. Emerg Med J 28(10):870–872
Mitra B, Mori A, Cameron PA, Fitzgerald M, Paul E, Street A (2010) Fresh frozen plasma (FFP) use during massive blood transfusion in trauma resuscitation. Injury 41(1):35–39
Molenaar IQ, Warnaar N, Groen H, Tenvergert EM, Slooff MJ, Porte RJ (2007) Efficacy and safety of antifibrinolytic drugs in liver transplantation: a systematic review and meta-analysis. Am J Transplant 7(1):185–194
Morse BC, Dente CJ, Hodgman EI, Shaz BH, Nicholas JM, Wyrzykowski AD, Salomone JP, Vercruysse GA, Rozycki GS, Feliciano DV (2011) The effects of protocolized use of recombinant factor VIIa within a massive transfusion protocol in a civilian level I trauma center. Am Surg 77(8):1043–1049
Murad MH, Stubbs JR, Gandhi MJ, Wang AT, Paul A, Erwin PJ, Montori VM, Roback JD (2010) The effect of plasma transfusion on morbidity and mortality: a systematic review and meta-analysis. Transfusion 50(6):1370–1383
Murphy GJ, Reeves BC, Rogers CA, Rizvi SI, Culliford L, Angelini GD (2007) Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation 116(22):2544–2552
Nascimento B, Lin Y, Callum J, Reis M, Pinto R, Rizoli S (2011) Recombinant factor VIIa is associated with an improved 24-hour survival without an improvement in inpatient survival in massively transfused civilian trauma patients. Clinics (Sao Paulo) 66(1):101–106
Nienaber U, Innerhofer P, Westermann I, Schöchl H, Attal R, Breitkopf R, Maegele M (2011) The impact of fresh frozen plasma vs coagulation factor concentrates on morbidity and mortality in trauma-associated haemorrhage and massive transfusion. Injury 42(7):697–701
Noval-Padillo JA, León-Justel A, Mellado-Miras P, Porras-Lopez F, Villegas-Duque D, Gomez-Bravo MA, Guerrero JM (2010) Introduction of fibrinogen in the treatment of hemostatic disorders during orthotopic liver transplantation: implications in the use of allogenic blood. Transplant Proc 42(8):2973–2974
Novikova N, Hofmeyr GJ (2010) Tranexamic acid for preventing postpartum haemorrhage. Cochrane Database Syst Rev (7):CD007872
Nunez TC, Young PP, Holcomb JB, Cotton BA (2010) Creation, implementation, and maturation of a massive transfusion protocol for the exsanguinating trauma patient. J Trauma 68(6):1498–1505
Nuttall GA, Oliver WC, Santrach PJ, Bryant S, Dearani JA, Schaff HV, Ereth MH (2001) Efficacy of a simple intraoperative transfusion algorithm for nonerythrocyte component utilization after cardiopulmonary bypass. Anesthesiology 94(5):773–781
O’Connell KA, Wood JJ, Wise RP, Lozier JN, Braun MM (2006) Thromboembolic adverse events after use of recombinant human coagulation factor VIIa. JAMA 295(3):293–298
O’Keeffe T, Refaai M, Tchorz K, Forestner JE, Sarode R (2008) A massive transfusion protocol to decrease blood component use and costs. Arch Surg 143:686–690
Pereboom IT, de Boer MT, Haagsma EB, Hendriks HG, Lisman T, Porte RJ (2009) Platelet transfusion during liver transplantation is associated with increased postoperative mortality due to acute lung injury. Anesth Analg 108(4):1083–1091
Perry DJ, Fitzmaurice DA, Kitchen S, Mackie IJ, Mallett S (2010) Point-of-care testing in haemostasis. Br J Haematol 150(5):501–514
Pybus S, Maccormac A, Houghton A, Martlew V, Thachil J (2012) Inappropriateness of fresh frozen plasma for abnormal coagulation tests. J R Coll Physicians Edinb 42(4):294–300
Rahe-Meyer N, Pichlmaier M, Haverich A, Solomon C, Winterhalter M, Piepenbrock S, Tanaka KA (2009a) Bleeding management with fibrinogen concentrate targeting a high-normal plasma fibrinogen level: a pilot study. Br J Anaesth 102(6):785–792
Rahe-Meyer N, Solomon C, Winterhalter M, Piepenbrock S, Tanaka K, Haverich A, Pichlmaier M (2009b) Thromboelastometry-guided administration of fibrinogen concentrate for the treatment of excessive intraoperative bleeding in thoracoabdominal aortic aneurysm surgery. J Thorac Cardiovasc Surg 138(3):694–702
Rajesparan K, Biant LC, Ahmad M, Field RE (2009) The effect of an intravenous bolus of tranexamic acid on blood loss in total hip replacement. J Bone Joint Surg Br 91(6):776–783
Rao SV, Kaul PR, Liao L, Armstrong PW, Ohman EM, Granger CB, Califf RM, Harrington RA, Eisenstein EL, Mark DB (2008) Association between bleeding, blood transfusion, and costs among patients with non-ST-segment elevation acute coronary syndromes. Am Heart J 155(2):369–374
Riskin DJ, Tsai TC, Riskin L, Hernandez-Boussard T, Purtill M, Maggio PM, Spain DA, Brundage SI (2009) Massive transfusion protocols: the role of aggressive resuscitation versus product ratio in mortality reduction. J Am Coll Surg 209:198–205
Roback JD, Caldwell S, Carson J, Davenport R, Drew MJ, Eder A, Fung M, Hamilton M, Hess JR, Luban N, Perkins JG, Sachais BS, Shander A, Silverman T, Snyder E, Tormey C, Waters J, Djulbegovic B, American Association for the Study of Liver; American Academy of Pediatrics; United States Army; American Society of Anesthesiology; American Society of Hematology (2010) Evidence-based practice guidelines for plasma transfusion. Transfusion 50(6):1227–1239
Rossaint R, Bouillon B, Cerny V, Coats TJ, Duranteau J, Fernández-Mondéjar E, Hunt BJ, Komadina R, Nardi G, Neugebauer E, Ozier Y, Riddez L, Schultz A, Stahel PF, Vincent JL, Spahn DR, Task Force for Advanced Bleeding Care in Trauma (2010) Management of bleeding following major trauma: an updated European guideline. Crit Care 14(2):R52
Rotter T, Kinsman L, James E, Machotta A, Gothe H, Willis J, Snow P, Kugler J (2010) Clinical pathways: effects on professional practice, patient outcomes, length of stay and hospital costs. Cochrane Database Syst Rev (3):CD006632
Ruppert A, Steinle T, Lees M (2011) Economic burden of venous thromboembolism: a systematic review. J Med Econ 14(1):65–74
Sambasivan CN, Kunio NR, Nair PV, Zink KA, Michalek JE, Holcomb JB, Schreiber MA; Trauma Outcomes Group, Wade CE, Brasel KJ, Vercruysse G, MacLeod J, Dutton RP, Hess JR, Duchesne JC, McSwain NE, Muskat P, Johannigamn J, Cryer HM, Tillou A, Cohen MJ, Pittet JF, Knudson P, De Moya MA, Tieu B, Brundage S, Napolitano LM, Brunsvold M, Sihler KC, Beilman G, Peitzman AB, Zenait MS, Sperry J, Alarcon L, Croce MA, Minei JP, Kozar R, Gonzalez EA, Stewart RM, Cohn SM, Bulger EM, Cotton BA, Nunez TC, Ivatury R, Meredith JW, Miller P, Pomper GJ, Marin B (2011) High ratios of plasma and platelets to packed red blood cells do not affect mortality in nonmassively transfused patients. J Trauma 71(2 Suppl 3):S329–S336
Sander M, Spies CD, Martiny V, Rosenthal C, Wernecke KD, von Heymann C (2010) Mortality associated with administration of high-dose tranexamic acid and aprotinin in primary open-heart procedures: a retrospective analysis. Crit Care 14(4):R148
Sarani B, Dunkman WJ, Dean L, Sonnad S, Rohrbach JI, Gracias VH (2008) Transfusion of fresh frozen plasma in critically ill surgical patients is associated with an increased risk of infection. Crit Care Med 36(4):1114–1118
Sarode R, Refaai MA, Matevosyan K, Burner JD, Hampton S, Rutherford C (2010) Prospective monitoring of plasma and platelet transfusions in a large teaching hospital results in significant cost reduction. Transfusion 50(2):487–492
Scalea TM, Bochicchio KM, Lumpkins K, Hess JR, Dutton R, Pyle A, Bochicchio GV (2008) Early aggressive use of fresh frozen plasma does not improve outcome in critically injured trauma patients. Ann Surg 248(4):578–584
Schaden E, Saner FH, Goerlinger K (2013) Coagulation pattern in critical liver dysfunction. Curr Opin Crit Care 19(2):142–148
Schöchl H, Nienaber U, Hofer G, Voelckel W, Jambor C, Scharbert G, Kozek-Langenecker S, Solomon C (2010) Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care 14(2):R55
Schöchl H, Nienaber U, Maegele M, Hochleitner G, Primavesi F, Steitz B, Arndt C, Hanke A, Voelckel W, Solomon C (2011) Transfusion in trauma: thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy. Crit Care 15(2):R83
Schöchl H, Maegele M, Solomon C, Görlinger K, Voelckel W (2012) Early and individualized goal-directed therapy for trauma-induced coagulopathy. Scand J Trauma Resusc Emerg Med 20:15
Schöchl H, Schlimp CJ, Voelckel W (2013) Potential value of pharmacological protocols in trauma. Curr Opin Anaesthesiol 26. doi:10.1097/ACO.0b013e32835cca92. [Epub ahead of print 2013 Jan 14]
Schofield N, Sugavanam A, Mallett S (2012) Blood product usage and fibrinolysis in liver transplantation before and after cessation of aprotinin. Liver Transplant 18(Suppl 1):S113
Schuster KM, Davis KA, Lui FY, Maerz LL, Kaplan LJ (2010) The status of massive transfusion protocols in United States trauma centers: massive transfusion or massive confusion? Transfusion 50(7):1545–1551
Shakur H, Elbourne D, Gülmezoglu M, Alfirevic Z, Ronsmans C, Allen E, Roberts I (2010) The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial. Trials 11:40
Shander A (2007) Financial and clinical outcomes associated with surgical bleeding complications. Surgery 142(4 Suppl):S20–S25
Shander A, Hofmann A, Gombotz H, Theusinger OM, Spahn DR (2007) Estimating the cost of blood: past, present, and future directions. Best Pract Res Clin Anaesthesiol 21(2):271–289
Shander A, Hofmann A, Ozawa S, Theusinger OM, Gombotz H, Spahn DR (2010) Activity-based costs of blood transfusions in surgical patients at four hospitals. Transfusion 50(4):753–765
Shander A, Javidroozi M, Ozawa S, Hare GM (2011) What is really dangerous: anaemia or transfusion? Br J Anaesth 107(Suppl 1):i41–i59
Shander A, Van Aken H, Colomina MJ, Gombotz H, Hofmann A, Krauspe R, Lasocki S, Richards T, Slappendel R, Spahn DR (2012) Patient blood management in Europe. Br J Anaesth 109(1):55–68
Sharples L, Buxton M, Caine N, Cafferty F, Demiris N, Dyer M, Freeman C (2006) Evaluation of the ventricular assist device programme in the UK. Chapter 6: Analysis of patient-specific data on resource use and costs. Health Technol Assess 10(48):67–72
Shore-Lesserson L, Manspeizer HE, DePerio M, Francis S, Vela-Cantos F, Ergin MA (1999) Thromboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery. Anesth Analg 88(2):213–319
Simpson E, Lin Y, Stanworth S, Birchall J, Doree C, Hyde C (2012) Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia. Cochrane Database Syst Rev (3):CD005011
Snyder CW, Weinberg JA, McGwin G Jr, Melton SM, George RL, Reiff DA, Cross JM, Hubbard-Brown J, Rue LW 3rd, Kerby JD (2009) The relationship of blood product ratio to mortality: survival benefit or survival bias? J Trauma 66(2):358–362
Solomon C, Collis RE, Collins PW (2012) Haemostatic monitoring during postpartum haemorrhage and implications for management. Br J Anaesth 109:851–863
Sørensen B, Spahn DR, Innerhofer P, Spannagl M, Rossaint R (2011) Clinical review: prothrombin complex concentrates – evaluation of safety and thrombogenicity. Crit Care 15(1):201
Spalding GJ, Hartrumpf M, Sierig T, Oesberg N, Kirschke CG, Albes JM (2007) Cost reduction of perioperative coagulation management in cardiac surgery: value of “bedside” thrombelastography (ROTEM). Eur J Cardiothorac Surg 31(6):1052–1057
Spannagl M, Dick A, Junker R (2010) POCT in coagulation. Quality assurance. Hamostaseologie 30(2):82–90
Spiess BD, Gillies BS, Chandler W et al (1995) Changes in transfusion therapy and reexploration rate after institution of a blood management program in cardiac surgical patients. J Cardiothorac Vasc Anesth 9:168–173
Spiess BD, Royston D, Levy JH, Fitch J, Dietrich W, Body S, Murkin J, Nadel A (2004) Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes. Transfusion 44(8):1143–1148
Spinella PC, Holcomb JB (2009) Resuscitation and transfusion principles for traumatic hemorrhagic shock. Blood Rev 23(6):231–240
Stanworth SJ, Grant-Casey J, Lowe D, Laffan M, New H, Murphy MF, Allard S (2011a) The use of fresh-frozen plasma in England: high levels of inappropriate use in adults and children. Transfusion 51(1):62–70
Stanworth SJ, Walsh TS, Prescott RJ, Lee RJ, Watson DM, Wyncoll D, Intensive Care Study of Coagulopathy (ISOC) investigators (2011b) A national study of plasma use in critical care: clinical indications, dose and effect on prothrombin time. Crit Care 15(2):R108
Stokes ME, Ye X, Shah M, Mercaldi K, Reynolds MW, Rupnow MF, Hammond J (2011) Impact of bleeding-related complications and/or blood product transfusions on hospital costs in inpatient surgical patients. BMC Health Serv Res 11:135
Stürmer KM, Neugebauer E, Deutsche Gesellschaft für Unfallchirurgie (federführend). S3-Leitlinie Polytrauma/Schwerverletzten-Behandlung. AWMF online 07/2011. http://www.awmf.org/uploads/tx_szleitlinien/012-019l_S3_Polytrauma_Schwerverletzten-Behandlung_2011-07_01.pdf
Sugg RM, Gonzales NR, Matherne DE, Ribo M, Shaltoni HM, Baraniuk S, Noser EA, Grotta JC (2006) Myocardial injury in patients with intracerebral hemorrhage treated with recombinant factor VIIa. Neurology 67(6):1053–1055
Sukeik M, Alshryda S, Haddad FS, Mason JM (2011) Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement. J Bone Joint Surg Br 93(1):39–46
Tavares M, DiQuattro P, Nolette N, Conti G, Sweeney J (2011) Reduction in plasma transfusion after enforcement of transfusion guidelines. Transfusion 51(4):754–761
The Board of the German Medical Association on the Recommendation of the Scientific Advisory Board (Bundesärztekammer) (2009) Chapter 7 – Procoagulators. Cross-sectional guidelines for therapy with blood components and plasma derivatives, 4th edn. Transfus Med Hemother. 36(6):419–436
The Board of the German Medical Association on the Recommendation of the Scientific Advisory Board (Bundesärztekammer) (2009) Chapter 4 – Plasma for therapeutic use. Cross-sectional guidelines for therapy with blood components and plasma derivatives, 4th edn. Transfus Med Hemother 36(6):388–397
Theusinger OM, Felix C, Spahn DR (2012) Strategies to reduce the use of blood products: a European perspective. Curr Opin Anaesthesiol 25(1):59–65
Toner RW, Pizzi L, Leas B, Ballas SK, Quigley A, Goldfarb NI (2011) Costs to hospitals of acquiring and processing blood in the US: a survey of hospital-based blood banks and transfusion services. Appl Health Econ Health Policy 9(1):29–37
Toulon P, Ozier Y, Ankri A, Fléron MH, Leroux G, Samama CM (2009) Point-of-care versus central laboratory coagulation testing during haemorrhagic surgery. A multicenter study. Thromb Haemost 101(2):394–401
Tripodi A, Mannucci PM (2011) The coagulopathy of chronic liver disease. N Engl J Med 365(2):147–156
Trzebicki J, Flakiewicz E, Kosieradzki M, Blaszczyk B, Kołacz M, Jureczko L, Pacholczyk M, Chmura A, Lagiewska B, Lisik W, Wasiak D, Kosson D, Kwiatkowski A, Lazowski T (2010) The use of thromboelastometry in the assessment of hemostasis during orthotopic liver transplantation reduces the demand for blood products. Ann Transplant 15(3):19–24
Tzortzopoulou A, Cepeda MS, Schumann R, Carr DB (2008) Antifibrinolytic agents for reducing blood loss in scoliosis surgery in children. Cochrane Database Syst Rev (3):CD006883
Varney SJ, Guest JF (2003) The annual cost of blood transfusions in the UK. Transfus Med 13(4):205–218
Vekeman F, LaMori JC, Laliberte F et al (2011) Risks and cost burden of venous thromboembolism and bleeding for patients undergoing total hip or knee replacement in a managed-care population. J Med Econ 14(3):324–334
Vogt KN, Van Koughnett JA, Dubois L, Gray DK, Parry NG (2012) The use of trauma transfusion pathways for blood component transfusion in the civilian population: a systematic review and meta-analysis. Transfus Med 22(3):156–166
Wang G, Bainbridge D, Martin J, Cheng D (2009) The efficacy of an intraoperative cell saver during cardiac surgery: a meta-analysis of randomized trials. Anesth Analg 109(2):320–330
Wang SC, Shieh JF, Chang KY, Chu YC, Liu CS, Loong CC, Chan KH, Mandell S, Tsou MY (2010) Thromboelastography-guided transfusion decreases intraoperative blood transfusion during orthotopic liver transplantation: randomized clinical trial. Transplant Proc 42(7):2590–2593
Warmuth M, Mad P, Wild C (2012) Systematic review of the efficacy and safety of fibrinogen concentrate substitution in adults. Acta Anaesthesiol Scand 56(5):539–548
Watson GA, Sperry JL, Rosengart MR, Minei JP, Harbrecht BG, Moore EE, Cuschieri J, Maier RV, Billiar TR, Peitzman AB, Inflammation and Host Response to Injury Investigators (2009) Fresh frozen plasma is independently associated with a higher risk of multiple organ failure and acute respiratory distress syndrome. J Trauma 67(2):221–227
Waydhas C, Görlinger K (2009) Coagulation management in multiple trauma. Unfallchirurg 112(11):942–950
Weber CF, Görlinger K, Meininger D, Herrmann E, Bingold T, Moritz A, Cohn LH, Zacharowski K (2012) Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. Anesthesiology 117(3):531–547
Zehtabchi S, Nishijima DK (2009) Impact of transfusion of fresh-frozen plasma and packed red blood cells in a 1:1 ratio on survival of emergency department patients with severe trauma. Acad Emerg Med 16(5):371–378
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Görlinger, K., Kozek-Langenecker, S.A. (2015). Economic Aspects and Organization. In: Marcucci, C., Schoettker, P. (eds) Perioperative Hemostasis. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-55004-1_24
Download citation
DOI: https://doi.org/10.1007/978-3-642-55004-1_24
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-55003-4
Online ISBN: 978-3-642-55004-1
eBook Packages: MedicineMedicine (R0)